Hepatitis C

3 articles published between April 10, 2026 and August 12, 2026.

Covered in Living Well, Global Health and Body.

EXPLAINER

Milk thistle is the top-selling liver supplement. The best trials show no benefit.

A Cochrane review of 18 trials and an NIH-funded randomised trial both failed to show that milk thistle improves liver disease. Product quality is also inconsistent, with some pills contaminated or mislabelled.

4 min read

Europe nearly eliminated hepatitis B in young children. It will still miss 2030

ECDC data show near-zero hepatitis B in under-fives and vertical transmission below 2%, alongside five million chronic infections and only seven countries meeting the harm-reduction benchmark.

4 min read

ANALYSIS

Egypt cured millions of hepatitis C. Its liver cancer problem did not go away

Two 2026 reviews describe the same handover: as the virus recedes, obesity-driven fatty liver disease is moving into the space it occupied — in a population where roughly 40% of screened adults met obesity criteria.

4 min read

This page indexes this newspaper’s reporting on Hepatitis C. It is not a medical reference entry, and nothing here is medical advice. See our editorial standards.